Drug Research
Takeda to Manufacture and Provide 150 Million Doses of Novavax COVID-19 Vaccine Candidate to the Government of Japan
Takeda Pharmaceutical Company Limited announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) will purchase 150 million doses of Novavax’ vaccine...
Drug Research
Arecor Therapeutics Signs Formulation Agreement with Intas Pharmaceuticals
Arecor Therapeutics plc, a biopharmaceutical group advancing therapies to enable healthier lives, has signed a formulation agreement with Intas Pharmaceuticals Ltd.
Under this agreement, Arecor will...
Drug Research
Dr Reddy’s Lab gains on deal with Citius Pharma for anti-cancer agent E7777
Dr.Reddy's Laboratories rose 0.71% to Rs 4934 after the company signed a deal with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777...
Drug Research
Pfizer and BioNTech Announce Collaboration With Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
Pfizer Inc. and BioNTech SE announced the signing of a letter of intent with Eurofarma Laboratórios SA, a Brazilian biopharmaceutical company, to manufacture COMIRNATY (COVID-19...
Drug Research
Innovent Biologics, Bolt Biotherapeutics Enter Immuno oncology Alliance
Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines for cancer, metabolic, autoimmune and other diseases, and Bolt Biotherapeutics, Inc., a clinical-stage...
Drug Research
Shoreline Launches into Era of Cell Therapy with $4 Billion in Partnerships
Shoreline Biosciences, an immunotherapy company formed in 2020 during the early days of the COVID-19 pandemic, was propelled into the proverbial catbird’s seat this summer...
Drug Research
Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets
Abveris, Inc., and Abilita Bio, Inc., both privately held biotechnology companies, announce a joint research collaboration that will leverage the synergies between their platforms to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.